Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cardiac Biomarkers Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cardiac Biomarkers Testingmarket, defines the market attractiveness level of Cardiac Biomarkers Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cardiac Biomarkers Testing industry, describes the types of Cardiac Biomarkers Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cardiac Biomarkers Testing market and the development prospects and opportunities of Cardiac Biomarkers Testing industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cardiac Biomarkers Testing market in Chapter 13.
By Player:
Tosoh Corporation
Becton, Dickinson and Company
Danaher Corporation
Abbott Laboratories
F HOFFMANN-LA ROCHE LTD
PerkinElmer Inc
Bio-Rad Laboratories Inc
Thermo Fisher Scientific Inc
BioMerieux
Siemens AG
By Type:
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
By End-User:
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cardiac Biomarkers Testing Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cardiac Biomarkers Testing Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cardiac Biomarkers Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cardiac Biomarkers Testing Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cardiac Biomarkers Testing Market Analysis and Outlook to 2022
-
7.1 Global Cardiac Biomarkers Testing Consumption (2017-2022)
-
7.2 United States Cardiac Biomarkers Testing Consumption (2017-2022)
-
7.3 Europe Cardiac Biomarkers Testing Consumption (2017-2022)
-
7.4 China Cardiac Biomarkers Testing Consumption (2017-2022)
-
7.5 Japan Cardiac Biomarkers Testing Consumption (2017-2022)
-
7.6 India Cardiac Biomarkers Testing Consumption (2017-2022)
-
7.7 South Korea Cardiac Biomarkers Testing Consumption (2017-2022)
8 Region and Country-wise Cardiac Biomarkers Testing Market Analysis and Outlook to 2028
-
8.1 Global Cardiac Biomarkers Testing Consumption Forecast (2022-2028)
-
8.2 United States Cardiac Biomarkers Testing Consumption Forecast (2022-2028)
-
8.3 Europe Cardiac Biomarkers Testing Consumption Forecast (2022-2028)
-
8.4 China Cardiac Biomarkers Testing Consumption Forecast (2022-2028)
-
8.5 Japan Cardiac Biomarkers Testing Consumption Forecast (2022-2028)
-
8.6 India Cardiac Biomarkers Testing Consumption Forecast (2022-2028)
-
8.7 South Korea Cardiac Biomarkers Testing Consumption Forecast (2022-2028)
9 Global Cardiac Biomarkers Testing Market Outlook by Types and Applications to 2022
-
9.1 Global Cardiac Biomarkers Testing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Myocardial Muscle Creatine Kinase (CK-MB) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Troponins (T and I) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Myoglobin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Brain Natriuretic Peptide (BNPs) or NT-proBNP Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Ischemia-modified Albumin (IMA) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cardiac Biomarkers Testing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Myocardial Infarction Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Congestive Heart Failure Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Acute Coronary Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Atherosclerosis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cardiac Biomarkers Testing Market Outlook by Types and Applications to 2028
-
10.1 Global Cardiac Biomarkers Testing Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Myocardial Muscle Creatine Kinase (CK-MB) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Troponins (T and I) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Myoglobin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Brain Natriuretic Peptide (BNPs) or NT-proBNP Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Ischemia-modified Albumin (IMA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cardiac Biomarkers Testing Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Myocardial Infarction Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Congestive Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Acute Coronary Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Atherosclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cardiac Biomarkers Testing Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cardiac Biomarkers Testing Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cardiac Biomarkers Testing Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cardiac Biomarkers Testing Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cardiac Biomarkers Testing Market Competitive Analysis
-
14.1 Tosoh Corporation
-
14.1.1 Tosoh Corporation Company Details
-
14.1.2 Tosoh Corporation Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Tosoh Corporation Cardiac Biomarkers Testing Product and Service
-
14.2 Becton, Dickinson and Company
-
14.2.1 Becton, Dickinson and Company Company Details
-
14.2.2 Becton, Dickinson and Company Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Product and Service
-
14.3 Danaher Corporation
-
14.3.1 Danaher Corporation Company Details
-
14.3.2 Danaher Corporation Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Danaher Corporation Cardiac Biomarkers Testing Product and Service
-
14.4 Abbott Laboratories
-
14.4.1 Abbott Laboratories Company Details
-
14.4.2 Abbott Laboratories Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbott Laboratories Cardiac Biomarkers Testing Product and Service
-
14.5 F HOFFMANN-LA ROCHE LTD
-
14.5.1 F HOFFMANN-LA ROCHE LTD Company Details
-
14.5.2 F HOFFMANN-LA ROCHE LTD Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F HOFFMANN-LA ROCHE LTD Cardiac Biomarkers Testing Product and Service
-
14.6 PerkinElmer Inc
-
14.6.1 PerkinElmer Inc Company Details
-
14.6.2 PerkinElmer Inc Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 PerkinElmer Inc Cardiac Biomarkers Testing Product and Service
-
14.7 Bio-Rad Laboratories Inc
-
14.7.1 Bio-Rad Laboratories Inc Company Details
-
14.7.2 Bio-Rad Laboratories Inc Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bio-Rad Laboratories Inc Cardiac Biomarkers Testing Product and Service
-
14.8 Thermo Fisher Scientific Inc
-
14.8.1 Thermo Fisher Scientific Inc Company Details
-
14.8.2 Thermo Fisher Scientific Inc Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Thermo Fisher Scientific Inc Cardiac Biomarkers Testing Product and Service
-
14.9 BioMerieux
-
14.9.1 BioMerieux Company Details
-
14.9.2 BioMerieux Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 BioMerieux Cardiac Biomarkers Testing Product and Service
-
14.10 Siemens AG
-
14.10.1 Siemens AG Company Details
-
14.10.2 Siemens AG Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Siemens AG Cardiac Biomarkers Testing Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cardiac Biomarkers Testing
-
Figure Cardiac Biomarkers Testing Picture
-
Table Global Cardiac Biomarkers Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cardiac Biomarkers Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cardiac Biomarkers Testing Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cardiac Biomarkers Testing Consumption by Country (2017-2022)
-
Figure United States Cardiac Biomarkers Testing Consumption and Growth Rate (2017-2022)
-
Table Europe Cardiac Biomarkers Testing Consumption and Growth Rate (2017-2022)
-
Figure China Cardiac Biomarkers Testing Consumption and Growth Rate (2017-2022)
-
Figure Japan Cardiac Biomarkers Testing Consumption and Growth Rate (2017-2022)
-
Figure India Cardiac Biomarkers Testing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cardiac Biomarkers Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiac Biomarkers Testing Consumption Forecast by Country (2022-2028)
-
Figure United States Cardiac Biomarkers Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cardiac Biomarkers Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cardiac Biomarkers Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cardiac Biomarkers Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cardiac Biomarkers Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cardiac Biomarkers Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Myocardial Muscle Creatine Kinase (CK-MB) Consumption and Growth Rate (2017-2022)
-
Figure Global Troponins (T and I) Consumption and Growth Rate (2017-2022)
-
Figure Global Myoglobin Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Natriuretic Peptide (BNPs) or NT-proBNP Consumption and Growth Rate (2017-2022)
-
Figure Global Ischemia-modified Albumin (IMA) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Myocardial Infarction Consumption and Growth Rate (2017-2022)
-
Figure Global Congestive Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Coronary Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Atherosclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Myocardial Muscle Creatine Kinase (CK-MB) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Troponins (T and I) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Myoglobin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Natriuretic Peptide (BNPs) or NT-proBNP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ischemia-modified Albumin (IMA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Myocardial Infarction Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Congestive Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Coronary Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Atherosclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cardiac Biomarkers Testing Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cardiac Biomarkers Testing Export by Region (Top 5 Countries) (2017-2028)
-
Table Tosoh Corporation (Foundation Year, Company Profile and etc.)
-
Table Tosoh Corporation Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tosoh Corporation Cardiac Biomarkers Testing Product and Service
-
Table Becton, Dickinson and Company (Foundation Year, Company Profile and etc.)
-
Table Becton, Dickinson and Company Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton, Dickinson and Company Cardiac Biomarkers Testing Product and Service
-
Table Danaher Corporation (Foundation Year, Company Profile and etc.)
-
Table Danaher Corporation Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Corporation Cardiac Biomarkers Testing Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Cardiac Biomarkers Testing Product and Service
-
Table F HOFFMANN-LA ROCHE LTD (Foundation Year, Company Profile and etc.)
-
Table F HOFFMANN-LA ROCHE LTD Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table F HOFFMANN-LA ROCHE LTD Cardiac Biomarkers Testing Product and Service
-
Table PerkinElmer Inc (Foundation Year, Company Profile and etc.)
-
Table PerkinElmer Inc Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer Inc Cardiac Biomarkers Testing Product and Service
-
Table Bio-Rad Laboratories Inc (Foundation Year, Company Profile and etc.)
-
Table Bio-Rad Laboratories Inc Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories Inc Cardiac Biomarkers Testing Product and Service
-
Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Inc Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc Cardiac Biomarkers Testing Product and Service
-
Table BioMerieux (Foundation Year, Company Profile and etc.)
-
Table BioMerieux Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMerieux Cardiac Biomarkers Testing Product and Service
-
Table Siemens AG (Foundation Year, Company Profile and etc.)
-
Table Siemens AG Cardiac Biomarkers Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens AG Cardiac Biomarkers Testing Product and Service
-
